Log in to save to my catalogue

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-prolif...

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-prolif...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23225f8a56d246569bcac354c3c67f09

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies

About this item

Full title

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies

Publisher

Abingdon: Taylor & Francis

Journal title

Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.2191-2205

Language

English

Formats

Publication information

Publisher

Abingdon: Taylor & Francis

More information

Scope and Contents

Contents

New quinoline and isatin derivatives having the main characteristics of VEGFR-2 inhibitors was synthesised. The antiproliferative effects of these compounds were estimated against A549, Caco-2, HepG2, and MDA-MB-231. Compounds 13 and 14 showed comparable activities with doxorubicin against the Caco-2 cells. These compounds strongly inhibited VEGFR-...

Alternative Titles

Full title

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_23225f8a56d246569bcac354c3c67f09

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23225f8a56d246569bcac354c3c67f09

Other Identifiers

ISSN

1475-6366

E-ISSN

1475-6374

DOI

10.1080/14756366.2022.2110869

How to access this item